Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders

Annals of Hematology

Volumn 91, Issue 10, 2012, Pages 1563-1577

  Campioni, Diana ^a   Bardi, M Antonella ^a   Cavazzini, Francesco ^a   Tammiso, Elisa ^a   Pezzolo, Elisa ^a   Pregnolato, Emma ^a   Volta, Eleonora ^a   Cuneo, Antonio ^a   Lanza, Francesco ^b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b CREMONA HOSPITAL   (Italy)

Author keywords

Acute lymphoblastic leukemia; Bone marrow microenvironment; Chronic lymphocytic leukemia; Cytogenetic alterations; Mesenchymal cells; Molecular profile

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SCREENING; CELL LINEAGE; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPING; MALE; MESENCHYMAL STROMA CELL; MOLECULAR CLONING; MOLECULAR MODEL; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT;

AGED; BONE MARROW CELLS; CELLS, CULTURED; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOPLASTIC STEM CELLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84867337799     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1500-8     Document Type: Article

References (68)

1. Trentin JJ (1971) Determination of bone marrow stem cell differentiation by stromal hemopoietic inductive microenvironments (HIM). Am J Pathol 65:621-628
2. Mayani H, Guilbert LJ, Janowska-Wieczorek A (1992) Biology of the hemopoietic microenvironment. Eur J Haematol 49:225-233
3. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143
4. Rizzo R, Campioni D, Stignani M et al (2008) A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy 10:364-375
5. Schäfer R, Dominici M, Müller I et al (2009) Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tübingen, Germany. Cytotherapy 11:245-255
6. Le Blanc K, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus host disease: a phase II study. Lancet 371:1579-1586
7. Prockop DJ, Brenner M, Fibbe WE et al (2010) Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12:576-578
8. Mayani H (1996) Composition and function of the hemopoietic microenvironment in human myeloid leukemia. Leukemia 10:1041-1047
9. Varga G, Kiss J, Varkonyi J et al (2007) Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Pathol Oncol Res 13:311-319
10. Marcondes AM, Ramaakrishnan A, Deeg HJ (2009) Myloid malignancies and themarrow microenvironment: some recent studies in patients with MDS. Curr Canc Ther Rev 5:310-314
11. Payne CM, Greenberg B, Cromey D et al (1987) Morphological evidence of an altered bone marrow microenvironment in patients with acute non-lymphoblastic leukemia and myelodysplastic disorders. Exp Hematol 15:143-153
12. Tauro S, Hepburn MD, Peddie CM et al (2002) Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia 16:785-790
13. Aizawa S, Nakano M, Iwase O et al (1999) Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk Res 23:239-246
14. Campioni D, Moretti S, Ferrari L et al (2006) Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematological disorders: correlation with bone marrow microenvironment. Haematologica 91:364-368
15. Dührsen U, Hossfeld DK (1996) Stromal abnormalities in neoplastic bone marrow diseases. Ann Hematol 73:53-70
16. Deeg HJ, Beckham C, Loken MR et al (2000) Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndromes. Leuk Lymphoma 37:405-414
17. Lopez-Villar O, Garcia JL, Sanchez-Guijo FM et al (2009) Both expanded and uncultured stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome. Leukemia 23:664-672
18. Menendez P, Catalina P, Rodriguez R et al (2009) Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 206:3131-3141
19. Choumerianou DM, Dimitriou H, Perdikogianni C et al (2008) Study of oncogenic transformation in ex vivo expanded mesenchymal cells from pediatric bone marrow. Cell Prol 41:909-922
20. Blau O, Baldus CD, Hofmann WK et al (2011) Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloblastic leukemia have distinct genetic abnormalities compared with leukemic blasts. Blood 118:5583-5592
21. Klaus M, Stavroulaki E, Kastrinaki MC et al (2010) Reserves, functional, immunoregulatory and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Stem Cell Dev 19:1043-1054
22. Dimitriou H, Linardakis E, Martimianaki G et al (2008) Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic malignancies. Cytotherapy 10:125-133
23. Soenen-Cornu V, Tourino C, Bonnet ML et al (2005) Mesenchymal cells generated from patients with myelodysplastic syndrome (MDS) are devoid of chromosomal clonal markers and support short and long-term hematopoiesis in vitro. Oncogene 24:2441-2448
24. Flores-Figueroa E, Arana-Trejo RM, Gutièrrez-Espìndola G et al (2005) Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 29:215-224
25. Garayoa M, Garcia JL, Santamaria C et al (2009) Mesenchymal cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia 23:1515-1527.7
26. Ramakrishnan A, Awaya N, Bryant E et al (2006) The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS. Blood 108:772-773
27. Arnulf B, Lecourt S, Soulier J et al (2007) Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia 21:158-163
28. Burger JA, Kipps TJ (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk Lymphoma 43:461-466
29. Calligaris-Cappio F (2003) Role of the microenvironment in chronic lymphocytic leukaemia. Br J Haematol 123:380-388
30. Mudry RE, Fortney JE, York T et al (2000) Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 96:1926-1932
31. Ferretti E, Bertolotto M, Deaglio S et al (2011) A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia 25:1268-1277
32. Balakrishnan K, Burger JA, Quiroga MP et al (2010) Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells. Blood 116:1083-1091
33. Lagneaux L, Delforge A, Bron D et al (1998) Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 91:2387-2396
34. Castro-Malaspina H, Gay RE, Resnick G et al (1980) Characterization of human bone marrow fibroblast colony-forming cells (CFU) and their progeny. Blood 56:289-301
35. Campioni D, Lanza F, Moretti S et al (2008) Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from haematological patients may be induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy 10:69-82
36. Rooney DE (2001) Human cytogenetics: malignancy and acquired abnormalities. Oxford University Press, Oxford
37. Mitelman F (2005) Guidelines for cancer cytogenetics: supplement to an International System for Human Cytogenetics Nomenclature ISCN. Karger, Basel
38. Bigoni R, Cuneo A, Milani R et al (2001) Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears. Haematologica 86:375-381
39. Vianello F, Dazzi F (2008) Mesenchymal stem cells for graftversus- host disease: a double edged sword. Leukemia 22:463-465
40. Deeg HJ (2002) Marrow stroma in MDS: culprit or bystander? Leuk Res 26:687-688
41. Kurtova AV, Balakrishanan K, Chen R et al (2009) Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistence. Blood 114:4441-4450
42. Giannoni P, Scaglione S, Quarto R et al (2011) HGF-c-MET interaction prolongs chronic lymphocytic leukemic cells survival through STAT-3 phosphorylation: potential role of mesenchymal cells in the disease. Haematologica 96:1015-1023
43. Ding W, Nowakowski GS, Knox TR et al (2009) Bi-directional activation between mesenchymal stem cells and CLL-B- cells: implication for CLL disease progression. Br J Haematol 147:471-483
44. Tehranchi R, Woll PS, Anderson K et al (2010) Persistent malignant stem cells in del(5q) myelodysplasia in remission. N Engl J Med 363:1025-1037
45. Carrara RCV, Orellana MD, Fontes AM et al (2007) Mesenchymal stem cells from patients with chronic myloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant. Braz J of Med Biol Res 40:57-67
46. Bhatia R, McGlave PB, Dewald GW et al (1995) Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of the malignant stromal macrophages. Blood 85:3636-3645
47. Simmons PJ, Przepiorka D, Thomas ED et al (1987) Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328:429-432
48. Kastrinaki MC, Pontikoglou C, Klaus M et al (2011) Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes. Curr Stem Cell Res Ther 6:122-130
49. Achille V, Mantelli M, Arrigo G et al (2011) Cell cycle phases and genetic profile of bone marrow derived mesenchymal stromal cells expanded in vitro from healthy donors. J Cell Biochem 112:1817-1821
50. Foudah D, Redaelli S, Donzelli E et al (2009) Monitoring the genomic stability of in vitro cultured rat bone marrow-derived mesenchymal stem cells. Chromosome Res 17:1025-1039
51. Ogawa M, LaRue AC, Watson P (2010) Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches. Int J Hematol 91:353-359
52. Flores-Figueroa E, Mayani H (2006) Chromosomal abnormalities in marrow stromal cells from myelodysplastic syndrome (MDS). Blood 108:3948-3949
53. Yeh SP, Lo WJ, Liao YM et al (2010) Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cells. Ann Hematol 91:163-172
54. Shalapour S, Eckert C, Seeger K et al (2010) Leukemia-associated genetic aberrations in mesenchymal stem cell of children with acute lymphoblastic leukemia. J Mol Med 88:249-265
55. Iwamoto S, Mihara K, Downing JR et al (2007) Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 117:1049-1057
56. Greenberg BR, Wilson FD, Woo L et al (1978) Cytogenetics of fibroblasts colonies in Ph1-positive chronic myelogenous leukemia. Blood 51:1039-1044
57. Wilson FD, Greenberg BR, Konrad PN et al (1978) Cytogenetic studies on bone marrow fibroblasts from a male-female hematopoietic chimera. Transplantation 25:87-88
58. Jootar S, Pornprasertsud N, Petvises S et al (2006) Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t (9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Leuk Res 30:1493-1498
59. Dominici M, Le Blanc K, Müller I et al (2006) Minimal criteria for defining mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
60. Horwitz EM (2009) Culture conditions shape mesenchymal stromal cells phenotype and functions. Cytotherapy 11:101-102
61. Haniffa MA, Collin MP, Buckley CD et al (2009) Mesenchymal stem cells: the fibroblasts new clothes? Haematologica 94:258-263
62. Bononi A, Lanza F, Ferrari L et al (2009) Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery. Cytometry B Clin Cytom 76B:328-333
63. Nguyen HG, Ravid K (2010) Polyplody: mechanisms and cancer promotion in hematopoietic and other cells. Adv Exp Med Biol 676:105-122
64. Oberringer M, Jennewein M, Motsch SE et al (2005) Different cell cycle responses of wound healing protagonists to transient in vitro hypoxia. Histochem Cell Biol 123:595-603
65. Lee CC, Putnam AJ, Miranti CK et al (2004) Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration and cytokinesis. Oncogene 23:5193-5202
66. Zhang ZX, Guan LX, Zhang K et al (2007) Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro. Cell Biol Int 31:645-648
67. Ahmadbeigi N, Shafiee A, Seyedjafari E et al (2011) Early spontaneous immortalization and loss of plasticity of rabbit bone marrow mesenchymal stem cells. Cell Prolif 44:67-68
68. Döhner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New Engl J of Med 343:1910-1916